Divergent synthesis of crambescidin natural products and analogs

ORGN 671

Zachary D. Aron1, Larry E. Overman1, Halina Pietraszkiewicz2, and Fred Valeriote2. (1) Department of Chemistry, University of California, Irvine, 516 Rowland Hall, Irvine, CA 92697, (2) Josephine Ford Cancer Center, Division of Hematology and Oncology, Department of Internal Medicine, Henry Ford Health System, Wayne State University, Henry Ford Health System, One Ford Place, 1D, Detroit, MI 48202

 

The crambescidin family of natural products, characterized by a pentacyclic guanidinium core often tethered to a polar side chain, exhibit significant and unique cytotoxicity profiles.

The synthesis of crambescidins that vary in substitution at C14 is described. The key step of the synthetic route is Pd-catalyzed cleavage of a pentacyclic cinnamyl ester to generate core acid 1 as a key intermediate. Core acid 1 was directly esterified with various electrophiles to complete the first total synthesis of crambescidin 431 (2) and various crambescidin analogues. Cytotoxicities of these analogs have been obtained and a rudimentary SAR for the crambescidin side chain developed. Core acid 1 decomposes to form crambescidin 359 (3). Detailed examination of the decomposition of core acid 1 to generate 3 have lead to an improved understanding of the behavior of the pentacyclic core of the crambescidin alkaloids.

 

 

 

 

 

Total Synthesis of Complex Molecules
8:00 AM-12:00 PM, Thursday, September 11, 2003 Sheraton New York -- Imperial Ballroom B, Oral

Division of Organic Chemistry
The 226th ACS National Meeting, New York, NY, September 7-11, 2003